Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy

Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy - Clinical Studies on oral tolerance induction by slow oral immunothrapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023453

Enrollment

Registered

2016-08-13

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy

Interventions

allergen foods are slowly increasing to the target amount and continuing its amount until tolerance induction.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: food allergy patients who wish to join this study at the age of five or more.

Exclusion criteria

Exclusion criteria: 1; Patients using beta-blockers, 2; patients who are pregnant at the time of the start of treatment, 3; Patient who has the unstable severe asthma, 4; Patients with systemically serious disease (malignant tumors, autoimmune diseases, immune deficiencies, severe heart disease, chronic infections, etc.), 5; patients using continuous use systemic corticosteroids or anti-cancer agents, and 6; Patients who are suffering from acute infection.

Design outcomes

Primary

Measure	Time frame
Validation of Salava specific IgA for three years	—

Secondary

Measure	Time frame
Validation of Serum specific IgE for three years	—

Countries

Japan

Contacts

Public ContactYasuto Kondo

Fujita Health University, Second teaching Hospital Department of Pediatrics

ykondo@fujita-hu.ac.jp052-323-5649

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026